Spatial Proteomics Mass Spectrometry: Techniques and Applications

Spatial proteomics mass spectrometry is the set of analytical workflows that measure protein identity and abundance while retaining information about where those proteins reside within a tissue, cell, or organelle. For students, researchers, analysts, and life-science professionals, this field answers a question that conventional bulk proteomics cannot: which proteins are present in a specific anatomical region, cellular neighborhood, or subcellular compartment, and how do those spatial patterns change across health, disease, or experimental perturbation? This article covers the main mass spectrometry-based spatial proteomics techniques, their resolution and throughput tradeoffs, practical workflow decisions, quality controls, data interpretation limits, and applications in cancer research and neuroscience.

The Rationale for Spatial Proteomics

Bulk proteomics homogenizes tissue, averaging protein signals across millions of cells and losing the spatial context that often determines biological function. Protein subcellular localization is tightly controlled and directly linked to protein function in health and disease, so capturing the spatial proteome, defined as the localizations of proteins and their dynamics at the subcellular level, is essential for a complete understanding of cell biology [8]. Spatial proteomics methods address this gap by either imaging proteins directly in tissue sections or by isolating defined spatial regions before mass spectrometry analysis.

The field has matured substantially due to advances in microscopy, mass spectrometry, and machine learning applications for data analysis, enabling proteome-wide investigations of spatial cellular regulation [8]. Studies of the human proteome have begun to reveal a complex architecture that includes single-cell variations, dynamic protein translocations, changing interaction networks, and proteins localizing to multiple compartments [8]. Comparative spatial proteomics has also proven useful as a discovery tool for unraveling disease mechanisms [8].

Mass spectrometry-based spatial proteomics approaches fall into two broad categories. The first category, mass spectrometry imaging, uses a laser or spray to desorb and ionize molecules directly from tissue sections, generating ion images that map molecular distributions across the sample. The second category, region-resolved or single-cell proteomics, uses laser microdissection or other isolation methods to extract defined cells or regions, which are then processed and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Each category has distinct strengths, limitations, and appropriate applications.

At a Glance: Technique Comparison

The table below summarizes the main mass spectrometry-based spatial proteomics techniques, their typical spatial resolution, throughput characteristics, and primary use cases. These values represent general operational ranges reported in the literature and should be interpreted as guidance instead of fixed specifications.

Core Principles of Mass Spectrometry Imaging

Mass spectrometry imaging techniques share a common workflow: a tissue section is prepared, a matrix or ionization agent is applied if needed, and a laser or spray samples the surface at defined spatial coordinates. Each sampling point generates a mass spectrum, and the intensity of each mass-to-charge value is plotted against its spatial coordinate to produce an ion image.

MALDI Imaging Mass Spectrometry

Matrix-assisted laser desorption ionization imaging mass spectrometry (MALDI-IMS) allows acquisition of mass data for metabolites, lipids, peptides, and proteins directly from tissue sections [11]. The technique is typically performed either as a multiple spot profiling experiment to generate tissue-specific mass profiles or as a high-resolution imaging experiment where relative spatial abundance for potentially hundreds of analytes across virtually any tissue section can be measured [11]. A critical advantage is that imaging can be achieved without prior knowledge of tissue composition and without the use of antibodies [11]. This makes MALDI-IMS valuable for both cancer biomarker research and diagnostics because it generates molecular data that complement and expand upon the information provided by histology, including immunohistochemistry [11].

The choice of matrix is a central decision in MALDI-IMS experiments. Conventional matrices can suffer from low sensitivity at high spatial resolution, vacuum instability, or high toxicity [14]. Aminated cinnamic acid analogs (ACAAs) represent a newer class of dual-polarity matrices capable of acquiring 5 micrometer pixel sizes with high sensitivity toward polar lipids and metabolites [14]. These compounds are vacuum stable, have high extinction coefficients at 355 nanometers, are highly sensitive to polar lipids, have low toxicity, and are affordable [14]. Among these analogs, 4-aminocinnamic acid (ACA) and 4-(dimethylamino)cinnamic acid (DMACA) performed better than conventional MALDI matrices for lipid imaging experiments [14]. ACA generated fewer in-source fragments due to its high extinction coefficient at 355 nanometers, leading to better discernment of thermally labile molecules such as gangliosides compared to typical soft ionization matrices [14]. DMACA showed better optical properties than ACA, giving it higher sensitivity for many lipid classes such as phospholipids and sulfatides [14]. DMACA also allows lower laser power to be used without compromising sensitivity, which reduced the laser spot size at the sample surface from approximately 6 micrometers to approximately 4.5 micrometers without hardware modifications [14].

Desorption Electrospray Ionization

Desorption electrospray ionization (DESI) operates at ambient pressure and requires minimal sample preparation. A charged solvent spray is directed at the tissue surface, desorbing and ionizing molecules that are then introduced into the mass spectrometer. DESI is particularly suited for lipid and metabolite imaging because these molecules ionize efficiently under ambient conditions. Protein coverage is limited compared to MALDI because the ionization process is less efficient for large biomolecules. DESI offers the advantage of analyzing wet or untreated tissues, which can preserve native molecular distributions, but the spatial resolution is generally lower than what can be achieved with optimized MALDI matrices.

Region-Resolved and Single-Cell Proteomics

Region-resolved approaches isolate defined spatial areas before mass spectrometry analysis, enabling deep proteome coverage that imaging techniques cannot achieve.

Laser Capture Microdissection with Mass Spectrometry

Laser capture microdissection (LCM) uses a laser to cut and isolate specific cells or regions from a tissue section under microscopic guidance. The isolated material is then processed for LC-MS/MS analysis. This approach provides unbiased protein identification with deep coverage, often thousands of proteins per region. The spatial resolution is determined by the precision of the dissection, which can reach single-cell or even subcellular levels.

Single-cell proteomics by mass spectrometry is emerging as a powerful and unbiased method for the characterization of biological heterogeneity [5]. Historically, this approach was limited to cultured cells, but expansion to complex tissues has greatly enhanced biological insights [5]. Single-cell Deep Visual Proteomics (scDVP) integrates high-content imaging, laser microdissection, and multiplexed mass spectrometry to resolve the context-dependent spatial proteome of murine hepatocytes at a depth of 1,700 proteins from a cell slice [5]. In that study, half of the proteome was differentially regulated in a spatial manner, with protein levels changing dramatically in proximity to the central vein [5]. Machine learning applied to proteome classes and images subsequently inferred the spatial proteome from imaging data alone [5]. scDVP is applicable to healthy and diseased tissues and complements other spatial proteomics and spatial omics technologies [5].

Deep Visual Proteomics

Deep Visual Proteomics (DVP) combines artificial-intelligence-driven image analysis of cellular phenotypes with automated single-cell or single-nucleus laser microdissection and ultra-high-sensitivity mass spectrometry [9]. DVP links protein abundance to complex cellular or subcellular phenotypes while preserving spatial context [9]. In an archived primary melanoma tissue, DVP identified spatially resolved proteome changes as normal melanocytes transitioned to fully invasive melanoma, revealing pathways that change in a spatial manner as cancer progresses, such as mRNA splicing dysregulation in metastatic vertical growth that coincides with reduced interferon signaling and antigen presentation [9]. The ability of DVP to retain precise spatial proteomic information in the tissue context has implications for the molecular profiling of clinical samples [9].

DISCO-MS for Three-Dimensional Intact Specimens

DISCO-MS combines whole-organ or whole-organism clearing and imaging, deep-learning-based image analysis, robotic tissue extraction, and ultra-high-sensitivity mass spectrometry [7]. This technology yielded proteome data indistinguishable from uncleared samples in both rodent and human tissues [7]. DISCO-MS has been used to investigate microglia activation along axonal tracts after brain injury and to characterize early- and late-stage individual amyloid-beta plaques in a mouse model of Alzheimer's disease [7]. Robotic sample extraction enabled study of regional heterogeneity of immune cells in intact mouse bodies and aortic plaques in a complete human heart [7]. DISCO-MS enables unbiased proteome analysis of preclinical and clinical tissues after unbiased imaging of entire specimens in 3D, identifying diagnostic and therapeutic opportunities for complex diseases [7].

Practical Workflow Decisions

The choice of spatial proteomics technique depends on the biological question, sample type, available instrumentation, and desired molecular coverage. The following workflow decisions apply across techniques.

Sample Preparation

Tissue collection and preparation are critical determinants of data quality. Coolant-assisted liquid nitrogen flash freezing has been widely adopted to preserve tissue morphology for histopathological annotations in mass spectrometry-based spatial proteomics techniques [20]. However, existing coolants pose health risks upon inhalation and are expensive [20]. The EtOH-LN workflow uses 95 percent ethanol as a safer and easily accessible alternative to existing coolants for liquid nitrogen-based cryoembedding of frozen tissues [20]. Both the EtOH-LN and liquid nitrogen-only cryoembedding workflows exhibit significantly reduced freezing artifacts compared to cryoembedding in a cryostat, while EtOH-LN generates more consistent results compared to liquid nitrogen-only [20]. A morphology restoration method incorporating the EtOH-LN workflow successfully restored tissue architecture from freezing artifacts [20]. Additional studies are required to validate the impact of the EtOH-LN workflow on the molecular profiles of tissues [20].

For formalin-fixed paraffin-embedded (FFPE) tissue, antigen retrieval and on-tissue digestion protocols are required for protein analysis by MALDI-IMS. FFPE tissue is valuable because it represents the standard clinical archival format, and MALDI-IMS has been successfully applied to FFPE specimens for diagnostic classification [16].

Matrix Application for MALDI Imaging

Matrix application must produce uniform, small crystals that efficiently co-crystallize with analytes. Automated sprayers provide more reproducible matrix deposition than manual application. The matrix solvent composition, flow rate, and number of passes affect crystal size and analyte extraction. For high spatial resolution experiments, matrices that form small crystals and have high absorption at the laser wavelength are preferred [14].

Instrumentation and Acquisition Parameters

Mass spectrometry imaging experiments require careful selection of laser spot size, step size, and number of laser shots per pixel. Smaller step sizes increase spatial resolution but also increase acquisition time and data file size. The laser spot size at the sample surface determines the effective pixel size, and some matrices allow reduced laser spot size without hardware modifications [14].

For LC-MS/MS-based approaches, the sensitivity of the mass spectrometer determines the minimum amount of protein that can be analyzed. Ultra-high-sensitivity mass spectrometry is required for single-cell analyses [9,10]. Mass spectrometry-based proteomics has become a powerful technology to quantify the entire complement of proteins in cells or tissues, and recent advances in LC-MS-based analysis have enabled analysis of minute protein amounts down to the level of single cells [10].

Data Analysis and Computational Considerations

Spatial proteomics generates large, complex datasets that require specialized computational tools for processing, visualization, and interpretation.

Data Processing Pipelines

Mass spectrometry imaging data requires preprocessing steps including baseline correction, peak picking, and normalization. Automated annotation and visualization tools have been developed for high-resolution spatial proteomic mass spectrometry imaging data [25]. These tools reduce the manual burden of interpreting complex imaging datasets and enable reproducible analysis workflows.

For region-resolved and single-cell proteomics data, standard proteomics pipelines for peptide identification and quantification apply, but the low input amounts require careful quality control. The integration of spatial proteomics with other spatial omics modalities is an active area of development, with tools emerging to integrate, analyze, and interpret mass spectrometry imaging data alongside other molecular data types [19].

Machine Learning Integration

Machine learning plays an increasingly important role in spatial proteomics. In scDVP, machine learning applied to proteome classes and images inferred the spatial proteome from imaging data alone [5]. In DVP, artificial-intelligence-driven image analysis identifies cellular phenotypes that guide automated dissection [9]. Multimodal classification pipelines that combine histopathological images with mass spectrometry imaging data have demonstrated improved classification performance compared to either data type alone [17].

A multimodal pipeline using a pre-trained artificial neural network to extract morphological features from histopathological images and combine them with MALDI imaging mass spectrometry data achieved the best performance in classifying melanocytic neoplasia, with ROC-AUCs of 0.968 for the multimodal pipeline versus 0.938 for unimodal microscopy and 0.931 for unimodal imaging mass spectrometry [17]. Because this pipeline uses a pre-trained network for morphological feature extraction, it does not require training on large amounts of microscopy data and can be readily applied to other experimental settings where microscopy data is acquired in tandem with imaging mass spectrometry experiments [17].

Applications in Cancer Research

Spatial proteomics has found extensive application in cancer research, where the tumor microenvironment and intratumoral heterogeneity present complex spatial biology.

Tumor Classification and Diagnosis

MALDI imaging mass spectrometry has been applied to ovarian cancer classification and diagnosis [11]. The technique generates molecular data that complement and expand upon histology, making it valuable for both cancer biomarker research and diagnostics [11].

In dermatopathology, MALDI imaging mass spectrometry has been used to differentiate basal cell carcinoma from benign mimics such as trichoblastoma and trichoepithelioma [16]. In a cohort of 69 specimens, prediction models developed using a support vector machine classification model predicted basal cell carcinoma and trichoblastoma or trichoepithelioma with a sensitivity of 98.9 percent and specificity of 88.4 percent at the spectral level in the validation set when using tumor nests alone [16]. A model using stroma alone had lower sensitivity of 46.1 percent but higher specificity of 99.2 percent [16]. A combined model using both tumor nests and stroma achieved a sensitivity of 90.26 percent [16].

Multimodal approaches that combine imaging mass spectrometry with histopathological images have improved melanoma diagnosis [17]. Differentiating melanoma from nevi lesions is challenging solely by histopathologic evaluation, and imaging mass spectrometry provides promising avenues to augment histopathological investigation with rich spatio-molecular information [17].

Understanding Tumor Progression

Deep Visual Proteomics has revealed spatially resolved proteome changes during melanoma progression from normal melanocytes to fully invasive melanoma [9]. This approach identified pathways that change in a spatial manner as cancer progresses, including mRNA splicing dysregulation in metastatic vertical growth that coincides with reduced interferon signaling and antigen presentation [9].

Antibody-Drug Conjugate Development

MALDI imaging mass spectrometry has been used to spatially resolve the free payload distribution in tumors for antibody-drug conjugate (ADC) development [13]. In vivo studies in tumor-bearing murine models demonstrated comparable efficacy between DAR4 and DAR8 ADCs, suggesting that drug-to-antibody ratio alone does not dictate therapeutic outcome [13]. Immunohistochemical staining of human IgG demonstrated superior tumor penetration by DAR4 ADCs relative to DAR8 counterparts, but this enhanced penetration did not translate to improved therapeutic efficacy [13]. MALDI imaging mass spectrometry revealed similar intensity and distribution patterns for both DAR4 and DAR8 ADCs at 2 and 24 hours post-dosing, and this spatiotemporal uniformity of payload correlated with consistent pharmacodynamic responses [13]. These findings underscore that drug-to-antibody ratio optimization is both target-dependent and payload-specific, suggesting that ADC design should prioritize factors governing active payload release over passive distribution metrics [13].

Applications in Neuroscience

Spatial proteomics has provided insights into brain structure, function, and disease.

Brain Injury and Neurodegeneration

DISCO-MS was used to investigate microglia activation along axonal tracts after brain injury and to characterize early- and late-stage individual amyloid-beta plaques in a mouse model of Alzheimer's disease [7]. This technology enables unbiased proteome analysis of intact specimens in 3D, identifying diagnostic and therapeutic opportunities for complex diseases [7].

Substance Use Effects on Brain Protein Profiles

MALDI imaging mass spectrometry has been used to characterize peptide and protein profiles in five brain regions from rats exposed to cocaine and alcohol, alone and in combination [15]. Compared to exposure to cocaine or alcohol separately, the combination of cocaine and alcohol had a synergistic effect on the number of differentially expressed peptides and proteins detected in all regions, particularly the amygdala [15]. ANOVA revealed 13 differentially expressed peptides or proteins that varied significantly between all groups [15]. Gene ontology analysis indicated that most of the differentially expressed proteins found for the combined treatment are enriched in neuropeptide receptor binding, neuropeptide signaling, and regulation of circadian sleep and wake process pathways [15]. The combination of cocaine and alcohol significantly exacerbates the effects of each substance separately on the expression of peptides and proteins with multiple physiological functions, including opioid and GABA-ergic neurotransmission systems [15].

Vesicular Trafficking in Plant Neuroscience Models

While not directly neuroscience, spatial proteomics of vesicular trafficking in plants demonstrates the broader applicability of these methods [6]. Quantitative mass spectrometry and imaging approaches allow a system-wide dissection of the vesicular proteome, the characterization of ligand-receptor pairs, and the determination of secretory, endocytic, recycling, and vacuolar trafficking pathways [6]. These methodologies elucidate vesicle protein dynamics and interactions and their connections to downstream signaling outputs [6].

Subcellular Spatial Proteomics

Spatial proteomics extends beyond tissue-level analysis to subcellular resolution.

Organelle-Level Mapping

Protein subcellular localization is tightly controlled and linked to protein function [8]. Mass spectrometry-based spatial proteomics can map proteins to specific organelles and compartments. SubCellBarCode is an integrated workflow for robust spatial proteomics by mass spectrometry that enables classification of proteins to subcellular locations [21].

Endogenous Tagging Approaches

OpenCell combined genome engineering, confocal live-cell imaging, mass spectrometry, and data science to systematically map the localization and interactions of human proteins [12]. This approach provides a data-driven description of the molecular and spatial networks that organize the proteome [12]. Unsupervised clustering of these networks delineates functional communities that facilitate biological discovery [12]. The study found that remarkably precise functional information can be derived from protein localization patterns, which often contain enough information to identify molecular interactions, and that RNA binding proteins form a specific subgroup defined by unique interaction and localization properties [12].

Records and Measurements

Spatial proteomics experiments generate multiple data types that should be recorded systematically for reproducibility and quality assurance.

Essential Records

For mass spectrometry imaging experiments, record the tissue type and preparation method, matrix compound and application parameters, laser spot size and step size, number of laser shots per pixel, mass range and resolution settings, and calibration information. For LC-MS/MS-based approaches, record the dissection parameters, sample processing steps, LC gradients, mass spectrometer settings, and database search parameters.

Quality Metrics

Quality metrics for spatial proteomics include the number of identified proteins or features per pixel or region, the mass accuracy of detected features, the reproducibility of technical replicates, and the correlation between biological replicates. For imaging experiments, the spatial distribution of total ion current can reveal matrix application artifacts or tissue preparation issues.

Common Failure Patterns

Several recurring problems affect spatial proteomics experiments.

Freezing Artifacts

Improper tissue freezing introduces artifacts that compromise morphology and molecular preservation. Cryoembedding in a cryostat produces significantly more freezing artifacts than liquid nitrogen-based methods [20]. The EtOH-LN workflow reduces freezing artifacts and generates more consistent results than liquid nitrogen alone [20].

Matrix Application Inhomogeneity

Uneven matrix application produces spatial variation in signal intensity that can be mistaken for biological heterogeneity. Automated sprayers reduce this problem, but matrix crystal size and solvent composition still require optimization for each tissue type and analyte class.

Sensitivity Limitations at High Resolution

Increasing spatial resolution reduces the amount of analyte per pixel, which can compromise sensitivity. Some matrices, such as DMACA, allow lower laser power without compromising sensitivity, which reduces the laser spot size at the sample surface [14]. However, sensitivity at high spatial resolution remains a challenge for many analyte classes.

Contamination and Sample Loss

For single-cell and low-input analyses, contamination and sample loss are critical concerns. The low amounts of protein in single cells require ultra-high-sensitivity mass spectrometry and careful sample handling [10].

Limitations and Interpretation Boundaries

Spatial proteomics has inherent limitations that affect data interpretation.

Molecular Coverage

MALDI imaging mass spectrometry is limited to intact proteins under approximately 25 kilodaltons, while lipids, metabolites, and peptides are readily detected [11]. Larger proteins require on-tissue digestion or alternative approaches. LC-MS/MS-based methods provide deeper coverage but lose the direct spatial correlation of imaging.

Quantification

Mass spectrometry imaging provides relative abundance measurements, not absolute quantification. Comparisons across samples require careful normalization and experimental design. The relationship between ion intensity and actual protein abundance is influenced by ionization efficiency, matrix effects, and tissue composition.

Throughput

Single-cell and region-resolved approaches have lower throughput than imaging methods. The number of regions that can be analyzed in a single experiment is limited by the sensitivity of the mass spectrometer and the time required for LC-MS/MS analysis.

Tissue Heterogeneity

Spatial proteomics reveals heterogeneity but does not directly establish causality. Observed spatial patterns may reflect multiple cell types, extracellular matrix components, or technical artifacts. Integration with imaging data and other omics modalities is often necessary for biological interpretation.

Safety and Regulatory Context

Spatial proteomics involves several safety and regulatory considerations.

Chemical Safety

Traditional coolants used for tissue freezing pose health risks upon inhalation and are expensive [20]. The EtOH-LN workflow using 95 percent ethanol offers a safer alternative [20]. MALDI matrices may have toxicity concerns, and the development of low-toxicity matrices such as ACAAs addresses this issue [14].

Data Sharing and Genomic Data

Spatial proteomics data may be linked to genomic data from the same samples. Researchers should be aware of data sharing policies that apply to genomic and related data. The National Institutes of Health Genomic Data Sharing Policy provides expectations for sharing genomic data generated with NIH funding [3]. The FAIR Guiding Principles provide a framework for making data findable, accessible, interoperable, and reusable [4].

Training and Resources

Researchers entering the field should consult established training resources. The European Bioinformatics Institute provides training in bioinformatics and related topics [1]. The National Center for Biotechnology Information provides data resources and tools for molecular biology research [2].

Professional Escalation Criteria

Researchers should seek specialized expertise or escalate to appropriate professionals in specific situations.

When to Consult a Mass Spectrometry Specialist

Consult a mass spectrometry specialist when developing a new spatial proteomics workflow, when sensitivity is insufficient for the biological question, when troubleshooting unexplained signal variability, or when adapting a published protocol to a new tissue type or analyte class.

When to Consult a Pathologist

Consult a pathologist for tissue annotation, confirmation of histological features, and interpretation of spatial patterns in the context of tissue architecture. Pathologist input is essential for studies using clinical specimens and for validating that observed molecular patterns correspond to meaningful histological structures.

When to Consult a Bioinformatics Specialist

Consult a bioinformatics specialist for large-scale data processing, machine learning applications, integration of multimodal data, and statistical analysis of spatial patterns. The computational demands of spatial proteomics data often exceed the capabilities of standard desktop computers.

Frequently Asked Questions

What is the difference between MALDI imaging mass spectrometry and laser capture microdissection with LC-MS/MS?

MALDI imaging mass spectrometry generates ion images directly from tissue sections without isolating specific regions, providing spatial maps of hundreds of analytes in a single experiment [11]. Laser capture microdissection with LC-MS/MS physically isolates defined cells or regions before analysis, providing deeper proteome coverage but lower throughput. MALDI imaging is best for surveying molecular distributions across a tissue, while LCM-MS is best for deep characterization of specific cell populations.

What spatial resolution can be achieved with current mass spectrometry imaging techniques?

MALDI imaging mass spectrometry can achieve pixel sizes as small as 5 micrometers with optimized matrices such as aminated cinnamic acid analogs [14]. Conventional matrices typically achieve 10 to 200 micrometer resolution depending on the analyte class and instrumentation. DESI generally achieves lower resolution of 50 to 200 micrometers. Higher resolution requires smaller laser spot sizes, which reduces the amount of analyte per pixel and can compromise sensitivity.

Can spatial proteomics be performed on formalin-fixed paraffin-embedded tissue?

Yes, MALDI imaging mass spectrometry has been successfully applied to formalin-fixed paraffin-embedded tissue for diagnostic classification [16]. FFPE tissue requires antigen retrieval and on-tissue digestion protocols for protein analysis. The ability to analyze FFPE tissue is valuable because it represents the standard clinical archival format.

How many proteins can be identified from a single cell by mass spectrometry?

Single-cell Deep Visual Proteomics resolved the spatial proteome of murine hepatocytes at a depth of 1,700 proteins from a cell slice [5]. The number of proteins identified depends on the sensitivity of the mass spectrometer, the sample preparation method, and the cell type. Ultra-high-sensitivity mass spectrometry is required for single-cell analyses [10].

What is the role of machine learning in spatial proteomics?

Machine learning serves multiple roles in spatial proteomics. In Deep Visual Proteomics, artificial-intelligence-driven image analysis identifies cellular phenotypes that guide automated dissection [9]. In single-cell Deep Visual Proteomics, machine learning applied to proteome classes and images inferred the spatial proteome from imaging data alone [5]. Multimodal classification pipelines use deep learning to extract morphological features from histopathological images and combine them with imaging mass spectrometry data for improved classification [17].

How does spatial proteomics contribute to cancer diagnosis?

MALDI imaging mass spectrometry generates molecular data that complement and expand upon histology, making it valuable for cancer biomarker research and diagnostics [11]. It has been used to differentiate basal cell carcinoma from benign mimics with high sensitivity and specificity [16], to improve melanoma diagnosis through multimodal approaches [17], and to reveal spatially resolved proteome changes during cancer progression [9].

What are the main limitations of spatial proteomics?

The main limitations include restricted molecular coverage for imaging techniques, relative instead of absolute quantification, lower throughput for single-cell approaches, and the need for specialized instrumentation and computational infrastructure. MALDI imaging is limited to intact proteins under approximately 25 kilodaltons [11]. Single-cell analyses require ultra-high-sensitivity mass spectrometry [10]. Data interpretation often requires integration with imaging data and other omics modalities.

How should spatial proteomics data be shared and managed?

Spatial proteomics data should be managed according to the FAIR Guiding Principles to make data findable, accessible, interoperable, and reusable [4]. When spatial proteomics data is linked to genomic data, researchers should follow applicable data sharing policies such as the NIH Genomic Data Sharing Policy [3]. Training resources are available through organizations such as the European Bioinformatics Institute [1] and the National Center for Biotechnology Information [2].

Related Bioinformatics Guides

• Modern Transcriptomics: From Bulk RNA-Seq to Single-Cell and Spatial Resolution
• Docker and Containerization in Reproducible Research
• Neoantigen Prediction Algorithms in Cancer Immunotherapy
• The Rise of Omics: Genomics, Proteomics, and Metabolomics
• Spatial Transcriptomics: Mapping the Cellular Atlas

References and Further Reading

• EMBL-EBI Training. European Bioinformatics Institute.
• NCBI Data Resources. National Center for Biotechnology Information.
• Genomic Data Sharing Policy. National Institutes of Health.
• The FAIR Guiding Principles. Scientific Data.
• Spatial single-cell mass spectrometry defines zonation of the hepatocyte proteome.. Nature methods, 2023.
• Spatial proteomics of vesicular trafficking: coupling mass spectrometry and imaging approaches in membrane biology.. Plant biotechnology journal, 2023.
• Spatial proteomics in three-dimensional intact specimens.. Cell, 2022.
• Spatial proteomics: a powerful discovery tool for cell biology.. Nature reviews. Molecular cell biology, 2019.
• Deep Visual Proteomics defines single-cell identity and heterogeneity.. Nature biotechnology, 2022.
• Unbiased spatial proteomics with single-cell resolution in tissues.. Molecular cell, 2022.
• MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis.. International journal of molecular sciences, 2011.
• OpenCell: Endogenous tagging for the cartography of human cellular organization.. Science (New York, N.Y.), 2022.
• Spatiotemporal Profiling of Intratumoral Free Payload Distribution via MALDI Imaging Mass Spectrometry: Implications for Drug-to-Antibody Ratio Optimization in Antibody-Drug Conjugates.. 2026.
• Aminated cinnamic acid analogs as dual polarity matrices for high spatial resolution MALDI imaging mass spectrometry.. 2025.
• Combined administration of cocaine and alcohol alters the expression of brain peptide/protein profiles in rats: a MALDI imaging mass spectrometry approach.. 2025.
• MALDI imaging mass spectrometry differentiates basal cell carcinoma from trichoblastoma and trichoepithelioma: A proof of principle study.. 2025.
• Multimodal MALDI imaging mass spectrometry for improved diagnosis of melanoma.. 2024.
• Investigation of Phosphatidylcholine by MALDI Imaging Mass Spectrometry in Normal and IVF Early-Stage Embryos. 2024.
• PS.49 From spatial proteomics to spatial multiomics: leveraging spammR to integrate, analyze, and interpret mass spectrometry imaging data. Molecular &amp, Cellular Proteomics, 2025.
• EtOH-LN cryoembedding workflow to minimize freezing artifact in frozen tissues: A pilot study in preparing tissues compatible with mass spectrometry-based spatial proteomics application.. Cryobiology, 2023.
• SubCellBarCode: integrated workflow for robust spatial proteomics by mass spectrometry. Nature Protocols, 2022.
• Mass-spectrometry-based proteomics: from single cells to clinical applications. Nature, 2025.
• Advances and Applications of Mass Spectrometry Imaging in Tumor Spatial Proteomics Research. Journal of Chinese Mass Spectrometry Society, 2025.
• MS-based spatial proteomics: deciphering tissue microenvironment by bridging MS imaging and large-scale proteomics. Trends in Chemistry, 2025.
• Automated annotation and visualisation of high-resolution spatial proteomic mass spectrometry imaging data using HIT-MAP. Nature Communications, 2021.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.